| human | Q5 |
| P6178 | Dimensions author ID | 010771137677.64 |
| P496 | ORCID iD | 0000-0003-1945-5622 |
| P1153 | Scopus author ID | 57207903571 |
| P1416 | affiliation | Vanderbilt Department of Pediatrics | Q89953976 |
| P69 | educated at | University of South Florida | Q500606 |
| University of Miami | Q738258 | ||
| P108 | employer | Vanderbilt University | Q29052 |
| P735 | given name | James | Q677191 |
| James | Q677191 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q27860879 | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. |
| Q70832466 | A comparison of medical and surgical treatment of gastroesophageal reflux in severely retarded children |
| Q39450158 | A high school-based voluntary cardiovascular risk screening program: issues of feasibility and correlates of electrocardiographic outcomes |
| Q90568961 | A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys |
| Q80141768 | Accuracy of parental reporting of secondhand smoke exposure: The National Health and Nutrition Examination Survey III |
| Q23916439 | Accuracy of self-reported smoking and secondhand smoke exposure in the US workforce: the National Health and Nutrition Examination Surveys |
| Q30576375 | Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus |
| Q63816251 | Analysis of myocardial fibrosis in children with hypertrophic cardiomyopathy: A report from the pediatric cardiomyopathy registry |
| Q57153991 | Assessing the global and regional impact of primary cardiomyopathies: The Global Burden of Diseases, Injuries and Risk Factors (GBD 2010) Study |
| Q45089172 | Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy |
| Q85604842 | Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: differences between children and adults |
| Q38072951 | Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? |
| Q30736545 | Cancer among Hispanic women in South Florida: an 18-year assessment: a report from the Florida Cancer Data System |
| Q40396503 | Cancer incidence among Hispanic children in the United States |
| Q54559426 | Cancer trends among Hispanic men in South Florida, 1981-1998. |
| Q91345603 | Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry |
| Q47629689 | Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study |
| Q63816197 | Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children |
| Q34081675 | Cardiac biomarkers in HIV-exposed uninfected children |
| Q36941650 | Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America |
| Q35626381 | Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). |
| Q34881120 | Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers |
| Q34269964 | Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study |
| Q63816200 | Cardiac status of perinatally HIV-infected children |
| Q57795370 | Cardiac status of perinatally HIV-infected children: assessing combination antiretroviral regimens in observational studies |
| Q36240429 | Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry |
| Q92319821 | Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association |
| Q87382830 | Cardiomyopathy in children: importance of aetiology in prognosis--authors' reply |
| Q37312201 | Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry |
| Q33944043 | Clinical research directions in pediatric cardiology |
| Q30485861 | Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. |
| Q43746322 | Comparison of Gastric Intramucosal pH and Standard Perfusional Measurements in Pediatric Septic Shock |
| Q43530250 | Comparisons of French and U.S.A. pediatric intensive care units |
| Q35429435 | Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry |
| Q56435170 | Correction to Lancet HIV 2016; 3: e361-87 |
| Q38310280 | Current applications and Future Needs for Biomarkers in Pediatric Cardiomyopathy and Heart Failure: Summary From The Second International Conference On Pediatric Cardiomyopathy. |
| Q36988601 | Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus-Infected Individuals Treated With Highly Active Antiretroviral Therapy |
| Q24856547 | Declining trends in serum cotinine levels in US worker groups: the power of policy |
| Q63682647 | Department of Error |
| Q39792933 | Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures |
| Q38380886 | Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group |
| Q27860791 | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 |
| Q50242310 | Does Lowering Heart Rate Improve Outcomes in Children With Dilated Cardiomyopathy and Chronic Heart Failure? |
| Q23917100 | Earlier age at menopause, work, and tobacco smoke exposure |
| Q84978412 | Earlier stage at diagnosis and improved survival among Medicare HMO patients with breast cancer |
| Q98200132 | Elevated Heart Rate and Survival in Children With Dilated Cardiomyopathy: A Multicenter Study From the Pediatric Cardiomyopathy Registry |
| Q36691172 | Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children |
| Q28391248 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015 |
| Q23915092 | Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease |
| Q51782770 | Factors associated with establishing a causal diagnosis for children with cardiomyopathy. |
| Q63816279 | Future research directions in pediatric cardiomyopathy |
| Q28392340 | Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study |
| Q21534928 | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 |
| Q26782024 | Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q30358426 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 |
| Q24170269 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition |
| Q30061930 | Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. |
| Q21034169 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q28083357 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 |
| Q30409179 | Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q30061929 | Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. |
| Q30410700 | Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q30353189 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. |
| Q41686295 | Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. |
| Q36682865 | Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy |
| Q57914721 | Hepatocellular carcinoma incidence in Florida |
| Q50672314 | Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution. |
| Q95816568 | Idiopathic and Primary Cardiomyopathies in Children |
| Q35760873 | Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry |
| Q50791017 | Incidence, causes, and outcomes of dilated cardiomyopathy in children. |
| Q23915091 | Inflammatory markers and secondhand tobacco smoke exposure among U.S. workers |
| Q63816219 | Introduction |
| Q27023312 | Issues in solid-organ transplantation in children: translational research from bench to bedside. |
| Q91434032 | Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy |
| Q38588176 | Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) Study Group |
| Q37062155 | Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth |
| Q69454882 | Long-stay pediatric intensive care unit patients: outcome and resource utilization |
| Q45834486 | Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association |
| Q43563164 | Lymphoma and lymphoid leukemia incidence in Florida children: ethnic and racial distribution |
| Q30061943 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. |
| Q41461494 | Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit |
| Q57795501 | National Cancer Institute |
| Q50083073 | No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy |
| Q37313272 | Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review |
| Q68925318 | Outcome after assisted ventilation in children with acquired immunodeficiency syndrome |
| Q70028501 | Outcome of pediatric patients with multiple organ system failure |
| Q44370697 | Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry |
| Q38467055 | Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. |
| Q37520430 | Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies |
| Q36225409 | Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry |
| Q38662111 | Preventing pediatric cardiomyopathy: a 2015 outlook |
| Q63816286 | Progress in Pediatric Cardiology |
| Q45394887 | Proteinuria in children infected with the human immunodeficiency virus |
| Q33646290 | Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry |
| Q50084046 | Respiratory effects of secondhand smoke exposure among young adults residing in a "clean" indoor air state |
| Q30665383 | Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry |
| Q84995431 | Screening for long-term cardiac status during cancer treatment |
| Q79965858 | Secondhand smoke exposure and C-reactive protein levels in youth |
| Q46233514 | Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy |
| Q36691178 | The Pediatric Cardiomyopathy Registry: 1995-2007. |
| Q50129483 | The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma |
| Q63816265 | The danger of relying on the interpretation of p-values in single studies: Irreproducibility of results from clinical studies |
| Q81809739 | The effect of Medicare health care systems on women with breast and cervical cancer |
| Q83153927 | The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer |
| Q35032826 | The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy |
| Q40645797 | The injured child. An approach to care. |
| Q34160873 | The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years |
| Q80968551 | The relationship between nutritional and sociodemographic factors and the likelihood of children in the Dominican Republic having a BCG scar |
| Q57080461 | The “surreptitious staphylococcus”staphylococcus lugdunensis endocarditis in a child |
| Q37351693 | Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). |
| Q73217742 | Twenty-four-hour access to emergency care for children in managed care |
| Q38500138 | Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. |
| Q28111913 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 |
Search more.